Doximity (DOCS)
(Real Time Quote from BATS)
$72.20 USD
+0.12 (0.17%)
Updated Sep 17, 2025 02:20 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DOCS 72.20 +0.12(0.17%)
Will DOCS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOCS
Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know
HIMS' Personalized Wellness Platform Expands Preventive Care Access
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Other News for DOCS
Is DOCS signaling a buying opportunity? Upper Bollinger Band Walk shows up after dropping 0.54%
Pocket Pivot appears for DOCS after 2.03% move
Dr. Martens Enhances Employee Engagement with Share Incentive Plan
Pocket Pivot appears for DOCS after 1.1% move
Bank of America Securities Sticks to Their Hold Rating for Doximity (DOCS)